History, heresy and radiology in scientific discovery.
Nowadays, most drugs reach the market after research has established their pharmacology, safety and efficacy. That was not always the case 50 years ago. Thalidomide was used before its target cell or mode of action were known. Commencing with the thalidomide catastrophe--an epidemic of gross birth defects (1958-1962)--thalidomide's origins are revisited to show how this drug came to be made and sold in the 1950s. Thalidomide intersected with Australian radiology in the 1970s. The site and mode of action of the drug was deduced from X-rays of thalidomide-induced bone defects, which have classical radiological signs of sensory neuropathic osteoarthropathy. The longitudinal reduction deformities follow the distribution of segmental sensory innervation of the limb skeleton, indicating neural crest as the target organ. Injury to one level of neural crest halts normal neurotrophism and deletes the dependent segment--a previously unrecognised embryonic mechanism that explains most non-genetic birth defects. The final common pathway is neural crest injury and failure of normal neurotrophism to result in longitudinal reduction deformities, for example, phocomelia.
Department of Surgery, University of Sydney, New South Wales, Australia. janetmccredie@ozemail.com.au
J
J
McCredie
D000014:Abnormalities, Drug-Induced / Q000000981:diagnostic imaging* / Q000266:history*; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D011859:Radiography; D011871:Radiology / Q000266:history*; D012586:Science / Q000266:history*; D013792:Thalidomide / Q000009:adverse effects* / Q000266:history*
D013792:Thalidomide